| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036810 Cyclic amp response element activator proteins and uses related thereto |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036787 Insulin-induced gene as therapeutic target in diabetes |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036775 Method of modulating or examining Ku70 levels in cells |
| 02/15/2007 | US20070036770 Biologic device for regulation of gene expression and method therefor |
| 02/15/2007 | US20070036769 BMP pathway methods and compositions |
| 02/15/2007 | US20070036764 Selective killing of cells by activation of double-stranded RNA dependent protein kinase-PKR |
| 02/15/2007 | US20070036762 Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer |
| 02/15/2007 | US20070036761 Lentiviral apoe2 gene therapy |
| 02/15/2007 | US20070036760 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 02/15/2007 | US20070036759 Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same |
| 02/15/2007 | US20070036757 Aav vector for gene therapy |
| 02/15/2007 | US20070036756 Method for treating ischemic diseases |
| 02/15/2007 | US20070036721 Methods and compositions for in vivo inflammation monitoring |
| 02/15/2007 | US20070034220 Reduced-exposure tobacco products |
| 02/15/2007 | DE102005038036A1 Verfahren zur Herstellung von Arachidonsäure und/oder Eicosapentaensäure in transgenen Nutzpflanzen A process for the production of arachidonic acid and / or eicosapentaenoic acid in transgenic crops |
| 02/15/2007 | CA2656362A1 Cell nuclear transfer |
| 02/15/2007 | CA2625933A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 02/15/2007 | CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 02/15/2007 | CA2618796A1 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | CA2618779A1 Phosphoadenylyl sulfate reductase gene and use thereof |
| 02/15/2007 | CA2618769A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase |
| 02/15/2007 | CA2618657A1 Method for evaluating compound using molecule on the rb pathway as index and molecular diagnostic method |
| 02/15/2007 | CA2618650A1 Method for detecting colon cancer markers |
| 02/15/2007 | CA2618554A1 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | CA2618273A1 Expression of an active carrier for xylose in genetically modified saccharomyces cerevisiae |
| 02/15/2007 | CA2618160A1 Methods for carrying out the selective evolution of proteins in vivo |
| 02/15/2007 | CA2617982A1 Method for carrying out the selective evolution of proteins in vitro |
| 02/15/2007 | CA2617960A1 A novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 02/15/2007 | CA2617815A1 Methods for detection of a nucleic acid by sequential amplification |
| 02/15/2007 | CA2617714A1 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 02/15/2007 | CA2617506A1 Immunogenic constructs useful for treating mycobacterium avium subspecies paratuberculosis (map) infection |
| 02/15/2007 | CA2617483A1 Modified influenza virus for monitoring and improving vaccine efficiency |
| 02/15/2007 | CA2616810A1 Tri-block copolymers for nanosphere-based drug delivery |
| 02/15/2007 | CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/15/2007 | CA2615776A1 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | CA2611946A1 Expression vector and methods of producing high levels of proteins |
| 02/15/2007 | CA2602797A1 Creating poultry and other animals resistant to viral disease |
| 02/14/2007 | EP1752545A2 HIV probes for use in solution phase sandwich hybridization assays |
| 02/14/2007 | EP1752544A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same |
| 02/14/2007 | EP1752542A1 Novel method of generating non-human transgenic animals, and transgenic animals thus obtained |
| 02/14/2007 | EP1752541A1 Novel hiv-based recombinant viral clones and use thereof in analytical methods |
| 02/14/2007 | EP1752540A2 Non-human mutant mammals deficient in sigma receptors and their applications |
| 02/14/2007 | EP1752539A2 cDNA for human methylenetetrahydrofolate reductase |
| 02/14/2007 | EP1752538A1 Human bikunin |
| 02/14/2007 | EP1752537A1 9-fatty acid hydroperoxide lyase genes |
| 02/14/2007 | EP1752536A1 Polynucleotide causing rna interfere and method of regulating gene expression with the use of the same |
| 02/14/2007 | EP1752535A1 Dna amplification method |
| 02/14/2007 | EP1752534A1 High-speed pcr using high-speed dna polymerase |
| 02/14/2007 | EP1752533A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 02/14/2007 | EP1752525A1 Amylase variants |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752471A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 02/14/2007 | EP1752466A2 Process of purification of hcg and recombinant hcg purified by that method |
| 02/14/2007 | EP1752465A2 Linear VH-CH1-VH-CH1 heavy chain antibody fragment |
| 02/14/2007 | EP1752221A1 Automatic microinjection apparatus and cell trapping plate |
| 02/14/2007 | EP1752160A2 Epitope sequences |
| 02/14/2007 | EP1752040A1 Isolation of the t-complex distorters and applications thereof |
| 02/14/2007 | EP1751612A2 Methods and compositions for the treatment of uveitis |
| 02/14/2007 | EP1751312A2 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 02/14/2007 | EP1751311A2 Viral and viral associated mirnas and uses thereof |
| 02/14/2007 | EP1751298A1 Methods for dynamic vector assembly of dna cloning vector plasmids |
| 02/14/2007 | EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 02/14/2007 | EP1751290A2 Alphavirus replicon packaging constructs |
| 02/14/2007 | EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods |
| 02/14/2007 | EP1751288A2 Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production |
| 02/14/2007 | EP1751287A2 Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof |
| 02/14/2007 | EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 02/14/2007 | EP1751285A2 Pharmaceutical compositions for use in the treatment of allergic diseases, pathological changes of the respiratory system and cancer via modulation of stat6 gene expression |
| 02/14/2007 | EP1751283A1 Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale |
| 02/14/2007 | EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction |
| 02/14/2007 | EP1751280A2 Tobacco nicotine demethylase genomic clone and uses thereof |
| 02/14/2007 | EP1751279A2 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 02/14/2007 | EP1751278A2 Nicotiana nucleic acid molecules and uses thereof |
| 02/14/2007 | EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1751189A1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 02/14/2007 | EP1751188A1 Splice variant of unc5h2 |
| 02/14/2007 | EP1751184A2 Fgf-21 fusion proteins |
| 02/14/2007 | EP1751182A1 A novel human card-only protein that inhibits pro-il-1 beta; maturation |
| 02/14/2007 | EP1751181A1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS |
| 02/14/2007 | EP1751178A2 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 02/14/2007 | EP1750983A2 High protein soybean meal |
| 02/14/2007 | EP1750776A2 Oligonucleotides comprising a c5-modified pyrimidine |
| 02/14/2007 | EP1750775A2 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 02/14/2007 | EP1750773A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance |
| 02/14/2007 | EP1750772A1 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/14/2007 | EP1750771A2 Pancreatic islet microrna and methods for inhibiting same |
| 02/14/2007 | EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148 |
| 02/14/2007 | EP1750748A1 Use of the foamy virus bet protein for inactivating apobec |
| 02/14/2007 | EP1750720A2 Hepoxilins and modulators of ichthyin for treating skin disorders |
| 02/14/2007 | EP1750671A1 Liposomal assembly for therapeutic and/or diagnostic use |
| 02/14/2007 | EP1750666A2 Methods and articles for the delivery of therapeutic agents |
| 02/14/2007 | EP1750497A2 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom |
| 02/14/2007 | EP1656452B1 Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides |